Morepen’s Dubai Debut: New Subsidiary Set to Power Medtech Growth

Image Source: Express Healthcare

Morepen Laboratories Limited, a top Indian pharmaceutical and healthcare firm, has announced the establishment of a new subsidiary in Dubai as a strategic move to expand its medical devices business. The development is part of Morepen's overall strategy to consolidate operations and strengthen its global presence in the rapidly growing medical devices industry.

Background and Purpose

Morepen Laboratories is setting up a new subsidiary in Dubai, mainly to concentrate on its medical devices business and facilitate international growth.
The subsidiary, Morepen Medtech, was registered on January 8, 2025, and is intended to manage the medical devices segment as an independent entity.

Ownership and Structure

Morepen Laboratories will have an 80% equity holding in the new subsidiary, and the promoter group and their relatives will hold the remaining 20%.
The initial authorised and paid-up capital of the subsidiary is INR 10,00,000, divided into 1,00,000 equity shares of INR 10 each.

Business Transfer and Transaction Details

The Board of Directors has sanctioned the transfer of Morepen's current medical devices business to Morepen Medtech through a slump sale, pending regulatory and shareholder approvals.
The deal is expected to be concluded by September 30, 2025, subject to the satisfaction of all conditions stipulated in the Business Transfer Agreement (BTA).
The slump sale consideration shall be ascertained by an independent valuation of buildings, plant, machinery, and other assets and liabilities according to the effective date's balance sheet.

Strategic Rationale

By forming a dedicated subsidiary, Morepen will be offering operational autonomy and concentrated strategy to the medical devices business, permitting increased market responsiveness and efficiency.
The decision is consistent with the strategy of the company to leverage growing international demand for medical devices and increase its footing in overseas markets, especially in the Middle East.

Market Reaction

After making the announcement, shares of Morepen Laboratories increased positively, settling at ₹67.92, a 4.65% gain on the Bombay Stock Exchange.

Sources: Market Screenes, Express Healthcare, CNBC TV18

Stay Ahead – Explore Now! Avant Group Makes Strategic Entry Into Indian SaaS Market With Stake In Beyondsquare Solutions

STORIES YOU MAY LIKE

Image Source: EnTrackr

Transaction Triumph: Digital Payments Skyrocket to 99.8% Volume Share in H1 2025

Image Source: Cricketnmore

Unstoppable India! Women in Blue Storm into Semis with Commanding Win Over New Zealand

Image Source: ANI

Snackable Stories, Massive Downloads: Zupee Studio Reigns as India’s Short-Form Sensation

Image Source: Adgully

Elevate Your Ears: JioSaavn’s Affordable Pro Plan Unlocks Unlimited Music Freedom

Image Source: FinancialConsent

Sports.com’s Máximo Fútbol: More Than Just a Game — 10 Million Views and Counting as Season Two Approaches

Image Source: Instagram

Strategic Synergy: India and Armenia Deepen Defence Ties in Hyderabad Talks

Image Source: ANI News

Piyush Goyal Reaffirms India’s Commitment to Rules-Based Multilateral Trading at WTO Meeting

Top Searches

Suggestions

Morepen’s Dubai Debut: New Subsidiary Set to Power Medtech Growth

STORIES YOU MAY LIKE

Live Blogs

Top Stories

Morepen’s Dubai Debut: New Subsidiary Set to Power Medtech Growth

STORIES YOU MAY LIKE

Subscribe to receive the day's headlines from WOWNEWS 24X7 straight in your inbox

Live Blogs

Top Stories